Randomized Split-Face, Controlled Comparison of Treatment with 1565-Nm Nonablative Fractional Laser for Enlarged Facial Pores
W. Yu,J. Zhu,G. Ma,J. Yang,Y. Qiu,Y. Chen,H. Chen,Y. Jin,X. Yang,X. Hu,T. Wang,L. Chang,X. Lin
DOI: https://doi.org/10.1111/bjd.16115
IF: 11.113
2018-01-01
British Journal of Dermatology
Abstract:DEAR EDITOR, Enlarged pores are a common cosmetic concern. Although nonablative fractional lasers (NAFLs) have been used to reduce enlarged facial pores, a prospective, split-face, controlled study with objective assessment is lacking. A 1565-nm NAFL (M22 ResurFX; Lumenis, Yokneam, Israel) has proved effective on skin elasticity and stretch marks; therefore, we aimed to assess its safety and efficacy on enlarged facial pores. The present study was approved by the investigational review board of the Shanghai Ninth People’s Hospital (clinical trials registration number ChiCTR-ONh-16009094). We initially estimated an improvement of 40% on the treated side of the face vs. the nontreated side. To estimate sample size, we tested the null hypothesis that there would be a decrease of ≤ 10% in the number of enlarged pores between both sides of the face. With a sample size of 17, a 40% difference between the two sides would refute this hypothesis with a power of 80% and a 2 5% level of significance. In total, 22 participants with increased seborrhoea and enlarged pores were enrolled. Seventeen patients completed the study and five dropped out. Complaints of pain or oedema and personal reasons accounted for the dropouts. Based on a computer-generated randomization list, one side of the face was treated and the other side served as the control (Fig. 1a; further images are available from the corresponding author upon request). EMLA (Astra Pharmaceuticals, Oslo, Norway), a topical anaesthetic ointment (containing 25 mg lidocaine and 25 mg prilocaine), was applied 1 h before treatment. Spots measuring 17 mm with integrated contact cooling were used. A 38–40 mJ per microbeam laser was used for the first pass and 20–24 mJ per microbeam for the second; density was 300 microbeams per cm for both passes. The same parameters were used for a total of four treatments carried out at 2-week intervals. The quantitative number of pores was automatically calculated with the VISIA-CR imaging system (Canfield Scientific, Fairfield, NJ, U.S.A.) before treatment and 2 months after the final treatment. The device detects pores using an algorithm designed to detect circular objects of 0 4–1 0 mm in diameter. Feature analysis only occurs within automatically targeted zonal mask regions representing the best view, thereby reducing variability due to the camera angle. Use of the NAFL significantly decreased the number of facial pores (P < 0.001) post-treatment. The total average number of facial pores was 1015 on the NAFL-treated side and 1012 on the untreated side; these numbers decreased to 631 and 848, respectively, at the 2-month follow-up. The average pore reduction rate was 41 1% for the NAFL side and 16 5% for the untreated side (Fig. 1b–f). Missing data were not included. Participants were asked to rate the degree of pain immediately post-treatment using a visual analogue scale (VAS) ranging from 0 (no pain at all) to 10 (unbearable pain). Pain was reported as mild to moderate with a mean SD VAS score of 4 75 1 23. Other adverse events included immediate slightto-moderate erythema and oedema (100%), which continued for 2–4 days post-treatment. No permanent side-effects were seen. Compared with traditional ablative procedures, such as the CO2 fractional laser or the erbium–yttrium aluminum garnet fractional laser, NAFL allows for quicker healing with minimal downtime, low treatment discomfort and relatively fewer side-effects. Enlarged pores have been treated with an increasing focus on increased seborrhoea rather than as a component of photoageing. Only mild improvement of facial pores has been observed using a 1064-nm neodymium-doped yttrium aluminum garnet laser. Recently, NAFLs were introduced for skin resurfacing. Compared with the 1550/1540-nm laser, the 1565-nm NAFL has similar water absorption features. However, the newest CoolScan technique, as well as its integrated contact cooling system, has limited the bulk heating to the dermis, making it safer for sensitive or darker skin than other NAFLs. The ‘bystander effect’ may have contributed to the decrease of pores on the untreated side of the face. In the absence of any direct heating, heat diffusion or cell-to-cell contact, ‘bystander’ cells experience DNA damage, apoptosis and loss of viability when sharing the medium with heat-exposed cells. This is mostly found in dividing cells. We hypothesize that both bystander effects and an improvement in patient lifestyle contributed to skin resurfacing on the untreated sides of the face. The present study is the first split-face controlled trial using a 1565-nm NAFL with objective measurements for treating facial pores. Limitations include the low number of participants and the relatively brief follow-up period. The preliminary data show that a 1565-nm NAFL is significantly effective